Pharmacological characterization of the vesamicol analogue (+)-[(125)I]MIBT in primate brain.
Pharmacological characterization of the vesamicol analogue (+)-[(125)I]MIBT in primate brain.
复制标题
维萨米考类似物 ( )-[(125)I]MIBT 在灵长类动物脑中的药理学特征。
DOI:
10.1016/s0014-2999(97)81944-9
复制
发表时间:
1997
影响因子:
5
通讯作者:
Efange,SM
中科院分区:
文献类型:
--
作者:
Staley,JK;Mash,DC;Parsons,SM;Khare,AB;Efange,SM
The vesamicol analogue, meta-[125I ]iodobenzyltrozamicol [(+)-[125I ]MIBT] was evaluated as a probe for the in vitro labeling of the vesicular acetylcholine transporter in primate brain. In the striatum, (+)-[125I ]MIBT bound a single high-affinity site with a Kdvalue of 4.4±0.7 nM. Competition for (+)-[125I ]MIBT binding to the striatum by a group of vesamicol analogues displayed a pharmacological profile similar to the rank order of potency previously observed for the vesicular acetylcholine transporter on Torpedo synaptic vesicles. High-affinity binding of (+)-[125I ]MIBT in the occipital cortex was characterized by a Kdvalue of 4.6±1.1 nM. However, the rank order of potency for inhibition of (+)-[125I ]MIBT binding to the occipital cortex by the same test compounds differed from that observed in the striatum. The results suggest that (+)-[125I ]MIBT is a reliable probe of the vesicular acetylcholine transporter in primate striatum, but its binding in primate occipital cortex is more complex.